The current expectation is that every ovulatory menstrual cycle will have a luteal phase (the time from egg released until the next flow) that lasts approximately 14 days.
Rgenta obtains IND approval for RGT-61159 to treat cancers
The oral small molecule RNA modulator is intended to treat a range of cancers. Credit: Nemes Laszlo/Shutterstock. Rgenta Therapeutics has secured approval for its investigational